SCHEMBL1021023

SCHEMBL1021023

CS(=O)(=O)NC(=N)NC(=O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
GAA P10253 2/20 0.44
KMT2A Q03164 6/20 0.43
MEN1 O00255 4/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
KDM4E B2RXH2 3/20 0.42
EPHX1 P07099 2/20 0.42
HDAC3 O15379 1/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
IDO1 P14902 1/20 0.42
ALOX15 P16050 1/20 0.42
HDAC1 Q13547 1/20 0.42
CA9 Q16790 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HSD17B10 Q99714 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27523182 0.98 ALDH1A1 (0.43) ALDH1A1GAAKMT2AMEN1NPC1
Hydrochloric Acid SCHEMBL8895520 0.85 PTGES (0.49)
SCHEMBL13296132 0.82 RAB9A (0.55) ALDH1A1GAAKMT2AMEN1NPC1
SCHEMBL364110 0.81 HDAC3 (0.58) ALDH1A1GAAKMT2AMEN1KDM4E
SCHEMBL6933112 0.81 ALDH1A1 (0.57) ALDH1A1GAAKMT2AMEN1NPC1
Hydrochloric Acid SCHEMBL4438185 0.80 P4HTM (0.56) ALDH1A1GAAKMT2AMEN1KDM4E
SCHEMBL6651796 0.78 ALDH1A1 (0.50) ALDH1A1GAAKMT2AMEN1NPC1
Dimethylamine SCHEMBL15266781 0.78 HDAC3 (0.54) ALDH1A1GAAKMT2AMEN1KDM4E
SCHEMBL27334382 0.77 ALDH1A1 (0.55) ALDH1A1GAAKMT2AMEN1NPC1
SCHEMBL27480275 0.77 ALDH1A1 (0.55) ALDH1A1GAAKMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2271327-A1 PHARMACEUTICAL COMPOSITION COMPRISING RIMEPORIDE FOR TREATING DISEASES ASSOCIATED WITH INSULIN RESISTANCE AND BETA-CELL DYSFUNCTION Merck Patent GmbH (DE) 2011-01-12 EP disclosed
WO-2009135583-A1 PHARMACEUTICAL COMPOSITION COMPRISING RIMEPORIDE FOR TREATING DISEASES ASSOCIATED WITH INSULIN RESISTANCE AND BETA-CELL DYSFUNCTION MERCK PATENT GMBH (DE) 2009-11-12 WO disclosed
CN-1211370-C Imidazole derivatives with biphenylsulfonyl substituents, process for their preparation and their use as pharmaceuticals or diagnostic agents AVENTIS PHARMA GMBH (DE) 2005-07-20 CN disclosed
CN-1326928-A Biphenyl sulfonyl amino-cyanogen, its preparing method and use as medicine thereof AVENTIES PHARMACY GMBH (DE) 2001-12-19 CN disclosed
CN-1309645-A Imidazole derivatives with biphenylsulfonyl substituents, process for their preparation and their use as pharmaceuticals or diagnostic agents AVENTIS PHARMA GMBH (DE) 2001-08-22 CN disclosed
US-5968978-A ANTIARRYTHMIA AGENTS, ANTIISCHEMIC AGENTS, INHIBIT PROLIFERATION OF CELLS HOECHST MARION ROUSSEL DEUTSCHLAND (DE) 1999-10-19 US disclosed
CN-1212255-A Biphenylsulfonylcyanamides, method for the production thereof and use thereof as medicaments HOECHST MARION ROUSSEL DE GMBH (DE) 1999-03-31 CN disclosed